Skip to content

Study on the effect of liposomal bupivacaine on paravertebral analgesia after thoracic surgery

Study on the effect of liposomal bupivacaine on paravertebral analgesia after thoracic surgery

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087560
Enrollment
Unknown
Registered
2024-07-30
Start date
2024-04-18
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute pain after thoracic surgery

Interventions

Sponsors

Beijing Chest Hospital Affiliated to Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) 35-70 years old, gender unlimited, ASA Class I-III 2) Patients undergoing thoracoscopic lobectomy or segmental resection

Exclusion criteria

Exclusion criteria: 1) Patients who, in the opinion of the investigator, are not suitable for paravertebral block 2) Severe cardiovascular and cerebrovascular diseases 3) Patients with persistent chronic pain before surgery 4) Patients with abnormal liver and kidney function before surgery 5) Patients who are unable to express themselves verbally or do not respond to pain scores 6) Patient requests withdrawal from the study

Design outcomes

Primary

MeasureTime frame
The patient's NRS score;

Secondary

MeasureTime frame
NRS scores ;Opioid use ;The actual number of compressions and the effective number of compressions of the analgesic pump;Heart rate;Adverse reactions;The function of liver and kidney;QoR15 score;Complications;Blood pressure;oxygen saturation;

Countries

China

Contacts

Public ContactLiu Wei

Beijing Chest Hospital Affiliated to Capital Medical University

lw1200@sina.com+86 136 2115 3330

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026